New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.
Offering improved functionality of existing radiology information systems (RIS), a new partnership between RamSoft and Alpha Nodus may significantly enhance radiology workflow and address the time-consuming nature of prior authorizations.
RamSoft said the integration of the Gravity AI (Alpha Nodus) tools into its RIS offerings will streamline radiology workflows through increased automation. Alpha Nodus maintained that artificial intelligence (AI)-powered automation will reduce the burden of prior authorizations in radiology.
“Prior authorizations once took hours or even days," said Shamit Patel, the CEO of Alpha Nodus. "With Gravity, now integrated into PowerServer, we've fully automated or reduced that to just minutes, improving efficiency and accelerating the patient journey."
The companies said key benefits of the integration will include:
• real-time verification of payer requirements to prevent delays
• AI-enabled patient scheduling to reduce no-shows
• up to a 25 percent reduction of claim denial rates through compliance checks
RamSoft and Alpha Nodus will be showcasing the updated software at the Radiology Business Management Association (RBMA) Paradigm 2025 conference through March 27.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
SNMMI: Can Multimodal Monitoring Bolster Outcomes with Pluvicto in Treating mCRPC?
June 22nd 2025Multimodal treatment monitoring, including SPECT/CT exams 24 hours after treatment with Lu-177 PSMA-617, may have facilitated significantly shorter therapy durations and reduced side effects in patients with mCRPC, according to a two-year study presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
GE HealthCare Unveils Enhanced LesionID Pro at SNMMI Conference
Published: June 21st 2025 | Updated: June 21st 2025Emphasizing a zero-click experience, the updated LesionID Pro software, to be introduced at the SNMMI conference, reportedly provides AI-powered automated insights into whole-body tumor burden with PET and SPECT imaging.
